Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
Nature|December 21, 1989
Alternative splicing directs the expression of two D2 dopamine receptor isoformsB Giros, P Sokoloff, M P Martres, et al.In Vivo (Athens, Greece)|September 1, 1991
The amphibian embryo: an experimental model for the in vivo analysis of interactions between embryonic cells and extracellular matrix moleculesJ C Boucaut, T Darribere, D L Shi, et al.European Journal of Medicinal Chemistry|August 30, 2001
Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitorsI Tamburlin-Thumin, M P Crozet, J C Barrière, et al.Biochemical Pharmacology|October 19, 1993
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIA K Larsen, L Grondard, J Couprie, et al.Anti-Cancer Drug Design|June 1, 1995
Synthesis and biological evaluation of amino-substituted benzo[f]pyrido[4,3-b] and pyrido[3,4-b]quinoxalines: a new class of antineoplastic agentsC H Nguyen, E Fan, J F Riou, et al.The International Journal of Developmental Biology|December 1, 1994
Tenascin expression in developing, adult and regenerating caudal spinal cord in the urodele amphibiansX Caubit, J F Riou, J Coulon, et al.Chemical Communications (Cambridge, England)|February 3, 2018
Binding properties of mono- and dimeric pyridine dicarboxamide ligands to human telomeric higher-order G-quadruplex structuresC Saintomé, P Alberti, N Guinot, et al.Bioorganic & Medicinal Chemistry|August 1, 1996
Salen-anthraquinone conjugates. Synthesis, DNA-binding and cleaving properties, effects on topoisomerases and cytotoxicityS Routier, N Cotelle, J P Catteau, et al.Nucleic Acids Research|January 11, 2000
Interaction of human DNA topoisomerase I with G-quartet structuresP B Arimondo, J F Riou, J L Mergny, et al.Biochemical Pharmacology|August 27, 1998
Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug actionI Nabiev, F Fleury, I Kudelina, et al.Pageof 11